Effect of high dose statin therapy on platelet function; statins reduce aspirin resistant platelet aggregation in patients with coronary heart disease

Journal of Thrombosis and Thrombolysis

Volumn 27, Issue 1, 2009, Pages 24-28

  Tirnaksiz, Ebru ^a   Pamukcu, Burak ^a   Oflaz, Huseyin ^a   Nisanci, Yilmaz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Arterial thrombosis; Atorvastatin; Coronary heart disease; PFA 100; Platelet function assays; Platelet hyperreactivity, Aspirin resistance; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ATORVASTATIN; CHOLESTEROL; COLLAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SENSITIVITY; FEMALE; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PLEIOTROPY; PRIORITY JOURNAL; THERAPY RESISTANCE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; ADULT; AGED; ASPIRIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COLLAGEN; CORONARY DISEASE; DIABETES COMPLICATIONS; DRUG RESISTANCE; EPINEPHRINE; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PYRROLES; SMOKING;

EID: 60649084742     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0154-1     Document Type: Article

References (20)

1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial (2002) Lancet 360:7-22
2. Nissen SE, Tuzcu EM, Schoenhagen P, et al for the REVERSAL Investigators (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 291:1071-1080
3. Vaughan CJ, Gotto AM Jr, Basson CT (2000) The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 35:1-10
4. Relou IA, Hackeng CM, Akkerman JW, Malle E (2003) Low-density lipoprotein and its effect on human blood platelets. Cell Mol Life Sci 60(5):961-971
5. Mammen EF, Alsbameeri RS, Comp PC (1995) Preliminary data from a field trial of the PFA-100® system. Semin Thromb Hemost 21:113-121
6. Szapary L, Horvath B, Marton Z, Alexy T, Kesmarky G, Habon T, Szots M, Koltai K, Juricskay I, Czopf J, Toth K (2004) Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. CNS Drugs 18(3):165-172
7. Osamah H, Mira R, Sorina S, Shlomo K, Michael A (1997) Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br J Clin Pharmacol 44(1):77-83
8. Tekten T, Ceyhan C, Ercan E, Onbasili AO, Turkoglu C (2004) The effect of atorvastatin on platelet function in patients with coronary artery disease. Acta Cardiol 59(3):311-315
9. Thompson PD, Moyna NM, White CM, Weber KM, Giri S, Waters DD (2002) The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation. Atherosclerosis 161(2):301-306
10. Puccetti L, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Angori P, Auteri A, Bruni F (2002) Time-dependent effect of statins on platelet function in hypercholesterolaemia. Eur J Clin Invest 32(12):901-908
11. Cipollone F, Prontera C, Pini B, et al (2001) Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104:921-927
12. Belton O, Byrne D, Kearney D, Leahy A, Fitzgerald DJ (2000) Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 102:840-845
13. Larsson PT, Wallen NH, Hjemdahl P (1994) Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 89:1951-1957
14. Pamukcu B, Oflaz H, Acar RD, et al (2005) The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation. J Thromb Thrombolysis 20:17-22
15. Davis JW, Hartman CR, Lewis HD, et al (1985) Cigarette smoking-induced enhancement of platelet function: Lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 105:479-483
16. Santos MT, Valles J, Marcus AJ, et al (1991) Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 87:571-580
17. Kawasaki T, Ozeki Y, Igawa T, Kambayashi J (2000) Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke 31:591-595
18. Pamukcu B, Oflaz H, Nisanci Y (2005) The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis. Am Heart J 149:675-680
19. Jefferson BK, Foster JH, McCarthy JJ, et al (2005) Aspirin resistance and a single gene. Am J Cardiol 95:805-808
20. Maree AO, Curtin RJ, Chubb A, et al (2005) Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost 10:2340-2345